The proton pump inhibitor reduces amount of acid in the stomach.
(HealthDay)—The first generic version of the heartburn drug Nexium (esomeprazole) has been approved by the U.S. Food and Drug Administration.
Ivax Pharmaceuticals Inc., a subsidiary of Teva Pharmaceuticals U.S.A., received approval to market esomeprazole in 20- and 40-milligram capsules to treat gastroesophogeal reflux disease (GERD) in adults and children ages 1 and older, the FDA said Monday.
GERD stands for gastroesophageal reflux disease. GERD occurs when stomach acid backs into the esophagus, and is commonly known as chronic heartburn or acid reflux.
The capsules are also approved to reduce the risk of stomach ulcers associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs, such as aspirin, naproxen and ibuprofen). The capsules are also approved to treat the stomach infection Helicobacter pylori, along with certain antibiotics, and to treat conditions where the stomach makes too much acid, according to the FDA.
Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach.
"Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," Dr. Kathleen Uhl, director of the Office of Generic Drugs in the FDA's Center for Drug Evaluation and Research, said in an agency news release.
"It is important for patients to have access to treatment options for chronic conditions," she added.
The most serious risks when taking esomeprazole are stomach problems, including severe diarrhea. Also, people who take proton pump inhibitors for long periods of time are at increased risk for bone fractures, the FDA said.
Explore further: FDA approves generic version of celebrex
More information: The U.S. National Library of Medicine has more about GERD.
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
Generic aciphex approved to treat chronic heartburn
Nov 08, 2013
(HealthDay)—The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
FDA approves generic version of celebrex
Jun 03, 2014
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).
Tips on how to avoid holiday heartburn from a gastroenterologist
Dec 11, 2014
President Obama's recent diagnosis of acid reflux is prompting wide awareness of an ailment that is especially prevalent at this time of year. Fortunately, acid reflux and its complications can be avoided, as a Loyola gastroenterologist ...
Generic versions of plavix approved
May 18, 2012
(HealthDay) -- The first generic versions of Plavix (clopidogrel bisulfate) have been approved by the U.S. Food and Drug Administration.
Cyramza approved for stomach cancer
Apr 22, 2014
(HealthDay)—Cyramza (ramucirumab) has been approved by the U.S. Food and Drug Administration to treat cancer of the stomach or of the area where the esophagus joins the stomach (the gastroesophageal junction).
Recommended for you
Natpara approved for hormone disorder causing low blood calcium
2 hours ago
(HealthDay)—Natpara (parathyroid hormone) has been approved by the U.S. Food and Drug Administration to control low blood calcium among people with hypoparathyroidism.
FDA approves second vaccine against meningitis strain
Jan 23, 2015
Federal health regulators have approved a second vaccine to prevent a strain of bacteria that can cause deadly cases of meningitis.
Long-term use of hormonal contraceptives is associated with an increased risk of brain tumors
Jan 22, 2015
Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain. This project focussed on women aged 15 -49 years and ...
Only about half of teenage girls receive HPV vaccine at the CDC's recommended age
Jan 21, 2015
It's a virus that is responsible for almost all cases of cervical cancer but a new study by University of Texas Medical Branch at Galveston researchers indicates that only about half of the girls receive the vaccine at the ...
Medical charity warns India over patent rules
Jan 21, 2015
Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.
Why are some generic drugs getting so expensive?
Jan 21, 2015
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
The proton pump inhibitor reduces amount of acid in the stomach.
(HealthDay)—The first generic version of the heartburn drug Nexium (esomeprazole) has been approved by the U.S. Food and Drug Administration.
Ivax Pharmaceuticals Inc., a subsidiary of Teva Pharmaceuticals U.S.A., received approval to market esomeprazole in 20- and 40-milligram capsules to treat gastroesophogeal reflux disease (GERD) in adults and children ages 1 and older, the FDA said Monday.
GERD stands for gastroesophageal reflux disease. GERD occurs when stomach acid backs into the esophagus, and is commonly known as chronic heartburn or acid reflux.
The capsules are also approved to reduce the risk of stomach ulcers associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs, such as aspirin, naproxen and ibuprofen). The capsules are also approved to treat the stomach infection Helicobacter pylori, along with certain antibiotics, and to treat conditions where the stomach makes too much acid, according to the FDA.
Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach.
"Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," Dr. Kathleen Uhl, director of the Office of Generic Drugs in the FDA's Center for Drug Evaluation and Research, said in an agency news release.
"It is important for patients to have access to treatment options for chronic conditions," she added.
The most serious risks when taking esomeprazole are stomach problems, including severe diarrhea. Also, people who take proton pump inhibitors for long periods of time are at increased risk for bone fractures, the FDA said.
Explore further: FDA approves generic version of celebrex
More information: The U.S. National Library of Medicine has more about GERD.
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
Generic aciphex approved to treat chronic heartburn
Nov 08, 2013
(HealthDay)—The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
FDA approves generic version of celebrex
Jun 03, 2014
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).
Tips on how to avoid holiday heartburn from a gastroenterologist
Dec 11, 2014
President Obama's recent diagnosis of acid reflux is prompting wide awareness of an ailment that is especially prevalent at this time of year. Fortunately, acid reflux and its complications can be avoided, as a Loyola gastroenterologist ...
Generic versions of plavix approved
May 18, 2012
(HealthDay) -- The first generic versions of Plavix (clopidogrel bisulfate) have been approved by the U.S. Food and Drug Administration.
Cyramza approved for stomach cancer
Apr 22, 2014
(HealthDay)—Cyramza (ramucirumab) has been approved by the U.S. Food and Drug Administration to treat cancer of the stomach or of the area where the esophagus joins the stomach (the gastroesophageal junction).
Recommended for you
Natpara approved for hormone disorder causing low blood calcium
2 hours ago
(HealthDay)—Natpara (parathyroid hormone) has been approved by the U.S. Food and Drug Administration to control low blood calcium among people with hypoparathyroidism.
FDA approves second vaccine against meningitis strain
Jan 23, 2015
Federal health regulators have approved a second vaccine to prevent a strain of bacteria that can cause deadly cases of meningitis.
Long-term use of hormonal contraceptives is associated with an increased risk of brain tumors
Jan 22, 2015
Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain. This project focussed on women aged 15 -49 years and ...
Only about half of teenage girls receive HPV vaccine at the CDC's recommended age
Jan 21, 2015
It's a virus that is responsible for almost all cases of cervical cancer but a new study by University of Texas Medical Branch at Galveston researchers indicates that only about half of the girls receive the vaccine at the ...
Medical charity warns India over patent rules
Jan 21, 2015
Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.
Why are some generic drugs getting so expensive?
Jan 21, 2015
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment